Applying NanoGlass™
NanoGlass™
In Application
Platform-powered solutions for preclinical, clinical, and tox formulation challenges
SeraNovo partners with pharmaceutical and biotech companies to apply its proprietary formulation platforms to challenging drug candidates. Our technologies are designed to solve solubility, permeability, and dosing issues, delivering better outcomes in both toxicology and clinical development.
We provide access to our proprietary platform technologies, scientific expertise, and data-driven decision-making. The result is high-quality, optimized formulations that are built to perform in downstream development.
Pre-clinical and Clinical Formulations
Formulations developed using our proprietary platforms to maximize bioavailability, reduce dosing complexity, and ensure manufacturability for clinical progression.
GLP Tox Formulations
Formulations developed with the purpose of toxicology evaluations, that enable high systemic exposure, FDA alignment, cleaner interpretation of safety data, and simpler dosing regimens.
let's talk about your project
We work with a wide range of small molecules and protein degraders. Our aim is to help your program succeed by identifying the most effective formulation approach for your compound.
Get in touch to find out how our NanoGlass™ technology can help your drugs reach their full therapeutic potential
